HOME >> BIOLOGY >> NEWS
Dartmouth engineers closer to mass-producing therapeutic proteins

Hanover, N.H. -- Dartmouth engineers are one step closer to mass-producing therapeutic proteins desperately needed by today's pharmaceutical industry.

Reported in today's early online edition of the Proceedings of the National Academy Of Sciences, the researchers have achieved a major milestone in their efforts to effectively produce human therapeutics using a yeast-based protein expression system.

The research is the result of a collaborative effort between Dartmouth researchers and a bioengineering startup called GlycoFi, Inc. Founded by two Dartmouth engineering professors, GlycoFi is advancing technological solutions for the safe, fast, and cost-effective mass-production of fully-humanized proteins. Protein-based biological drugs must be manufactured by living cells, which are genetically engineered to produce (or express) proteins that mimic the structures synthesized by humans. Current production of these therapeutic proteins is being pushed beyond capacity by exponential growth in the biopharmaceutical industry. GlycoFi's business is to engineer fungal expression systems that produce therapeutic proteins with human-like structures at an industrial scale.

"Production capacity has led to a bottleneck within the biopharmaceutical pipeline," said Charles Hutchinson, co-founder and CEO of GlycoFi, as well as dean emeritus of Dartmouth's Thayer School of Engineering. "The result is that some approved therapeutic protein drugs cannot be produced in adequate amounts, and still others are not making it into commercialization due to the cost and inefficiencies of producing them. It is our hope that this push to producing homogeneous, human-like glycoproteins in yeast will eliminate the production capacity bottleneck, and allow for the production of better and safer drugs."

Fungal-based protein expression systems are safer than conventional mammalian cell culture systems, but have not been effective in replicating complex human glycoprot
'"/>

Contact: Catharine Lamm or Sue Knapp
catharine.lamm@dartmouth.edu
603-646-3943
Dartmouth College
17-Apr-2003


Page: 1 2

Related biology news :

1. Dartmouth Medical School awarded $9 million grant for genomics research
2. Dartmouth study advances prion disease research
3. Dartmouth bioengineers develop humanized yeast
4. Dartmouth researchers find two circadian clocks in the same plant tissue
5. Arsenic in drinking water may be linked to cancer Dartmouth study finds
6. Dartmouth researchers put recycling in perspective
7. Dartmouth Medical School geneticists discover new role for antisense RNA
8. Dartmouth researchers identify multi-tasking circadian protein
9. New way found to see light through novel protein identified by Dartmouth geneticists
10. Cancer killing gene found by Dartmouth researchers
11. Dartmouth biologists say algae might be missing mercury link in aquatic food chain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... October 11, 2018 , ... ODSC Europe 2018 - one of ... attendance at the event from September 19-22. , As Europe’s largest applied data ... 10 tracks and 4 days. Attendees were given key insights and hands-on training ...
(Date:10/11/2018)... ... October 11, 2018 , ... Better lives through a healthy ... Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Institute, a public-private partnership launched in March ... workforce development in the United States. Biopharmaceuticals are important because they treat and ...
(Date:10/5/2018)... ... October 04, 2018 , ... CallTower Inc., ... was present at Microsoft Ignite 2018, in Orlando, Florida, when Microsoft made a ... a statement about the new direction of Skype for Business Online, outlining the ...
Breaking Biology News(10 mins):
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. has announced ... the GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia ... and offer the GlycoMark test to its network of physicians through its sales ...
(Date:9/27/2018)... ... September 26, 2018 , ... NDA ... Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more ... industry has joined the firm as an Expert Consultant. Her experience includes leadership ...
(Date:9/27/2018)... ... September 26, 2018 , ... Medable ... that aims to build the first human digitome, a digital representation of human ... through a seamless integration of all data sources. Dr. Michelle Longmire, Co-Founder and ...
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend ... SureAdhere Mobile Technology, Inc. announced they will formally merge companies and integrate their ... tuberculosis (TB) and other diseases. These two social enterprise corporations, both of which ...
Breaking Biology Technology:
Cached News: